SLN

#3393
Silence Therapeutics Plc American Depository Share
6.12 USD
+1.83%
版块: 医疗保健
基础: USD
利润货币: USD
日范围
6.12
6.12
年范围
2.63
7.91
日变化
+1.83%
每月变动
-18.40%
6个月变化
+3.90%
年变化
+119.35%
前一天收盘价
6.01
开盘价
6.12
买价
卖价
最低价
6.12
High
6.12
交易量
41
展开完整图表

Financials

概览 声明 统计
每季度 年度
  • Market Capitalization 289.07 M
  • Employee 88
  • Founded 1994
  • CEO Craig A Tooman
  • Website www.silence-therapeutics.com
  • Headquarter United Kingdom
  • FIGI BBG00WVTHPN2
  • Industry Technology
总收入
净利润
每股基本收益（基本 EPS）
总债务
自由现金流
现金及现金等价物
市盈率
-9.65
市销率
1 541.15

Silence Therapeutics Plc - American Depository Share

Silence Therapeutics is a London-based pharmaceutical company formed in 1994. The company has pioneered the development of short-interfering ribonucleic acid therapeutics for the treatment of rare diseases. Silence Therapeutics has offices in London, New Jersey, and Berlin, with its corporate headquarters located in Hammersmith, London.

新闻